Prospective Randomized On-X Versus SJM Evaluation Trial (PROSE)
Thromboembolic Related Complications in a Randomized Trial of Previous and Current Generation Mechanical Valve Prostheses
Sponsor: On-X Life Technologies, Inc.
Listed as NCT00639782, this NA trial focuses on Heart Valve Disease and remains completed. Sponsored by On-X Life Technologies, Inc., it has been updated 11 times since 2003, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Apr 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Jul 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- On-X Life Technologies, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangalore, India , Bergen, Norway , Cape Town, South Africa , Chennai, India , Freiburg im Breisgau, Germany , Gothenburg, Sweden , Honolulu, United States , Jena, Germany , Los Angeles, United States , Ludhiana, India and 14 more locations